MedPath

Reducing relapse and recurrence in depression with continuation Cognitive Therapy: a randomized controlled trial.

Conditions
depressive disorder
depression
10027946
Registration Number
NL-OMON40027
Lead Sponsor
Arkin (Amsterdam)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
214
Inclusion Criteria

1. Two or more previous depressive episodes,
2. In remission according to DSM-IV criteria,
3. A current score of <14 on the Hamilton Rating Scale for Depression,
4. Received CT during the acute phase of the last episode.

Exclusion Criteria

1. Current mania or hypomania or a history of bipolar illness,
2. Any psychotic disorder (current and previous),
3. Alcohol or drug misuse,
4. Predominant anxiety disorder,
5. Insufficient mastering of the Dutch language.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome measure is the cumulative proportion of<br /><br>relapses/recurrences in a survival-analysis over a follow-up period of 15<br /><br>months after the start of the preventive therapy as measured with the<br /><br>*Structural Interview for DSM-IV (SCID) using the Longitudinal Interval<br /><br>Follow-up Evaluation (LIFE).</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath